Author: FierceBiotech News

After a series of large late-stage setbacks in Alzheimer’s in recent years, AstraZeneca and research partner Eli Lilly’s BACE inhibitor AZD3293 passed a safety analysis and will now move into the fina…

In this week’s EuroBiotech Report, Metabomed celebrated adding Pfizer to a list of investors that already featured the VC units of Merck KGaA and Boehringer Ingelheim. The Big Pharma trio joined toget…